Having shown success in the treatment of cancer, adoptive cell therapies employing naturally occurring allergen-specific regulatory T cells (Tregs) and chimeric antigen receptor (CAR)-T cells can be implemented in the management of IgE-mediated allergy [46]. The gene discussed is IGHE; the disease is Allergy.